Literature DB >> 20432906

[Effect of proteins extracted from mycelia of Omphalia lapidescens on inhibiting H, liver cancer in mice and regulating immune function].

Yi-tao Chen1, Mei-ai Lin, Dong-qing Cheng, Zhi-jian Shi, Jian-ling Zhu, Jian Wu.   

Abstract

OBJECTIVE: To explore the effect of proteins extraceed from mycelia of Omphalia lapidescens on inhibiting H22 liver cancer in vivo.
METHODS: 50 hepatoma 22 tumor bearing mice models were divided into five groups randomly:control group( CG), cyclophosphamide group, and 3 groups of incremental Hepatoma 22 dosages (5, 3, 1 mg/kg). All groups were i.v. with drugs once a day. After 8 consecutive days, the concentrations of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) in serum were detected by enzyme-linked immunoabsorbent assay (ELISA). The weight changes of tumor, thymus, liver, heart, spleen, lung and kidney were observed.
RESULTS: It showed the tumors' weight were significant heavier in CG than in EGs. The tumor-inhibition rate (IR) was 36.4% in high dosage group,which was lower than 43.2% in cyclophosphamide group. The spleen mass of proteins groups increased significantly. The concentration of IFN-gamma in serum of proteins groups increased as CG, but IL-4 in inverse direction. The observations of thymus, liver, heart, lung and kidney in EGs were the same as CG.
CONCLUSION: The proteins extracted from mycelium of Omphalia lapidescens can inhibit the growth of tumour and enhance the immune function of H22 tumor-bearing mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20432906

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  2 in total

Review 1.  Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside.

Authors:  Bing Hu; Shuang-Shuang Wang; Qin Du
Journal:  World J Hepatol       Date:  2015-05-28

2.  pPeOp from Omphalia lapidescens Schroet induces cell cycle arrest and inhibits the migration of MC-4 gastric tumor cells.

Authors:  Yong-Le Yang; Wei-Yao Gong; Fei-Fei Chen; Lu-Chao Chen; Yi-Tao Chen
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.